Further, we validated these observations in two additional BAP1-negative mesothelioma cell lines and consistently observed that genes belonging to cholesterol metabolism are upregulated upon treatment with an EZH2 inhibitor (Figures 5D and 5E). The gene discussed is EZH2; the disease is mesothelioma.